Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$72.7M
+68.8% from 2023
Prescriptions
369K
$196.77 per claim
Patients
159K
52,090 prescribers
Total spending, 2024
$72.7M
$457.21 per patient
Medicare prescription drug plans paid $72.7M for Diclofenac Potassium in 2024, for 369,335 prescriptions and refills to 158,988 patients (up 68.8% from 2023). The average cost per claim was $196.77.
New York had the highest Medicare cost for Diclofenac Potassium in 2024: $21.6M for 26,139 claims, followed by California ($17.1M).
Ivan Mikolaenko, critical care (intensivists) in Coral Springs, FL, had the highest Medicare cost for Diclofenac Potassium in 2024: 748 claims costing $1.8M.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Ivan Mikolaenko Coral Springs, FL | Critical Care (Intensivists) | 748 | 154 | $1.8M |
| Hangjun Jang Flushing, NY | Internal Medicine | 370 | 125 | $1.5M |
| Camil I Kreit |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 46,269 | 310,046 | 137,654 | $40.3M |
| 2023 | 49,560 | 334,079 | 147,919 | $43.0M |
| 2024 | 52,090 | 369,335 | 158,988 | $72.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Family Practice |
| 273 |
| 53 |
| $1.0M |
| Rivka Fischer Brooklyn, NY | Nurse Practitioner | 442 | 96 | $1.0M |
| Sarah Abdou Larchmont, NY | Podiatry | 303 | 41 | $850K |
| Gavriil Khaimov Fort Lee, NJ | Podiatry | 420 | 131 | $747K |
| Fausto A Gonzalez South Ozone Park, NY | Internal Medicine | 367 | 87 | $739K |
| Frantz Fils Saint-Louis Brooklyn, NY | Family Practice | 115 | 33 | $682K |
| Amable R Aguiluz Jr. Hawaiian Gardens, CA | General Practice | 302 | 62 | $646K |
| Ricardy Noncirel Delray Beach, FL | Nurse Practitioner | 128 | 98 | $635K |
| Megan Robinson Buda, TX | Nurse Practitioner | 131 | 98 | $581K |
| Gamil S Kostandy Brooklyn, NY | Internal Medicine | 125 | 36 | $533K |
| Mikhail Chilingaryan Pittsburgh, PA | General Practice | 325 | 50 | $505K |
| Susan N Kinyanjui Forney, TX | Nurse Practitioner | 82 | 61 | $490K |
| Amy L Blevins Knoxville, TN | Nurse Practitioner | 297 | 33 | $473K |
| Krikor B Tatoyan Van Nuys, CA | Internal Medicine | 171 | 38 | $472K |
| Monica Andres Miami, FL | Podiatry | 128 | 27 | $468K |
| Harry Lifschutz Indio, CA | General Surgery | 370 | 56 | $466K |
| Hong Chen Brooklyn, NY | Physician Assistant | 225 | 56 | $452K |
| Armen Kazanchian Glendale, CA | Internal Medicine | 242 | 43 | $433K |
| Tsovinar Tekkelian Glendale, CA | Internal Medicine | 285 | 47 | $418K |
| Kashif Irfan Mesquite, TX | Anesthesiology | 133 | 40 | $410K |
| Grant P Williams Glendale, CA | Interventional Pain Management | 171 | 21 | $405K |
| Svetlana Gorelikova Palmdale, CA | Internal Medicine | 82 | 22 | $394K |
| Kenneth E Roberts Ozark, AL | Family Practice | 108 | 20 | $388K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Ina Pharmaceuti | 13,952 | $31.0M |
| Trifluent Pharm | 6,556 | $14.9M |
| Cintex Services | 2,625 | $6.8M |
| Advagen Pharma | 148,000 | $6.8M |
| Teva USA TEVA | 80,673 | $3.6M |
| Carwin Associat | 1,462 | $3.1M |
| Avet Pharmaceut | 1,476 | $1.5M |
| Ingenus Pharmac | 36,201 | $984K |
| Zydus Pharmaceu ZYDUSLIFE.NS | 40,187 | $973K |
| Archis Pharma L | 30,712 | $708K |
| Leading Pharma | 1,118 | $708K |
| Camber Pharmace | 941 | $407K |
| Ascend Laborato ALKEM.NS | 1,054 | $383K |
| Amici Pharmaceu | 2,858 | $366K |
| Aurobindo Pharm AUROPHARMA.NS | 404 | $338K |
| Par Pharm. | 385 | $195K |
| Mylan/Archis Ph VTRS | 843 | $26K |